Cost-Utility Analysis of Angiotensin Receptor–Neprilysin Inhibitor Sacubitril/Valsartan Compared with Ace Inhibitors for the Treatment of Chronic Heart Failure in the United States

Abstract

Authors

RL Harrington PM Zueger VM Kumar G Rigoni AM Atwood RJ DiDomenico DR Touchette